Perindopril erbumine and Musculoskeletal pain - a phase IV clinical study of FDA data
Musculoskeletal pain is found among people who take Perindopril erbumine, especially for people who are female, 60+ old.
The phase IV clinical study analyzes which people take Perindopril erbumine and have Musculoskeletal pain. It is created by eHealthMe based on reports of 7,833 people who have side effects when taking Perindopril erbumine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,833 people reported to have side effects when taking Perindopril erbumine.
Among them, 21 people (0.27%) have Musculoskeletal pain.
What is Perindopril erbumine?
Perindopril erbumine has active ingredients of perindopril erbumine. It is often used in high blood pressure. eHealthMe is studying from 8,449 Perindopril erbumine users for its effectiveness, alternative drugs and more.
What is Musculoskeletal pain?
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves) is found to be associated with 2,766 drugs and 1,785 conditions by eHealthMe.
Number of Perindopril erbumine and Musculoskeletal pain reports submitted per year:
Gender of people who have Musculoskeletal pain when taking Perindopril erbumine *:
- female: 63.16 %
- male: 36.84 %
Age of people who have Musculoskeletal pain when taking Perindopril erbumine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 13.33 %
- 60+: 86.67 %
Common drugs people take besides Perindopril erbumine *:
- Nexium: 4 people, 19.05%
- Aspirin: 3 people, 14.29%
- Oxycodone: 3 people, 14.29%
- Folic Acid: 3 people, 14.29%
- Methotrexate: 3 people, 14.29%
- Acetaminophen: 2 people, 9.52%
- Cymbalta: 2 people, 9.52%
- Prevacid: 2 people, 9.52%
- Diclofenac: 2 people, 9.52%
- Pentasa: 2 people, 9.52%
Common side effects people have besides Musculoskeletal pain *:
- Joint Pain: 8 people, 38.10%
- Back Pain: 6 people, 28.57%
- Bone Pain: 5 people, 23.81%
- Dizziness: 5 people, 23.81%
- Malaise (a feeling of general discomfort or uneasiness): 5 people, 23.81%
- Pain: 5 people, 23.81%
- Weakness: 4 people, 19.05%
- Fatigue (feeling of tiredness): 4 people, 19.05%
- Pain In Extremity: 4 people, 19.05%
- Pain In Jaw: 3 people, 14.29%
Common conditions people have *:
- Osteoporosis (bones weak and more likely to break): 4 people, 19.05%
- High Blood Cholesterol: 2 people, 9.52%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 9.52%
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 2 people, 9.52%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.52%
- Dyslipidaemia (abnormal amount of lipids): 1 person, 4.76%
- Breathing Difficulty: 1 person, 4.76%
- Cardiac Failure: 1 person, 4.76%
- Cardiomyopathy (weakening of the heart muscle): 1 person, 4.76%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 4.76%
* Approximation only. Some reports may have incomplete information.
Do you take Perindopril erbumine and have Musculoskeletal pain?Check whether Musculoskeletal pain is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Krishnan K, Krishnasamy K, "Evaluation of anaphylactic reaction as an adverse event for perindopril erbumine tablets", International Current Pharmaceutical Journal, 2014 Mar .
How severe was Musculoskeletal pain and when was it recovered:
Expand to all the drugs that have ingredients of perindopril erbumine:
Alternative drugs to, pros and cons of Perindopril erbumine:
- Perindopril erbumine (8,449 reports)
Common Perindopril erbumine side effects:
- Breathing difficulty: 477 reports
- Malaise (a feeling of general discomfort or uneasiness): 419 reports
- Hypotension (abnormally low blood pressure): 409 reports
- Fatigue (feeling of tiredness): 406 reports
- Diarrhea: 402 reports
- Dizziness: 398 reports
- High blood pressure: 391 reports
Browse all side effects of Perindopril erbumine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Musculoskeletal pain treatments and more:
- Musculoskeletal pain (75,584 reports)
COVID vaccines that are related to Musculoskeletal pain:
- Musculoskeletal pain in Moderna COVID Vaccine
- Musculoskeletal pain in Pfizer BioNTech Covid Vaccine
- Musculoskeletal pain in Johnson and Johnson Covid Vaccine
Common drugs associated with Musculoskeletal pain:
- Enbrel: 8,447 reports
- Methotrexate: 7,016 reports
- Humira: 6,705 reports
- Prednisone: 5,802 reports
- Aspirin: 3,746 reports
- Xeljanz: 3,053 reports
- Actemra: 2,651 reports
- Orencia: 2,529 reports
- Sulfasalazine: 2,462 reports
- Lisinopril: 2,301 reports
All the drugs that are associated with Musculoskeletal pain:
- Musculoskeletal pain (2,766 drugs)
Common conditions associated with Musculoskeletal pain:
- Rheumatoid arthritis: 11,975 reports
- Osteoporosis: 3,903 reports
- High blood pressure: 3,208 reports
- Pain: 3,118 reports
- High blood cholesterol: 3,052 reports
- Multiple sclerosis: 2,593 reports
All the conditions that are associated with Musculoskeletal pain:
- Musculoskeletal pain (1,785 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on perindopril erbumine (the active ingredients of Perindopril erbumine) and Perindopril erbumine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Amlodipine Besylate and Terbutaline Sulfate drug interaction - 6 seconds ago
- Propofol and Mirtazapine drug interaction - 6 seconds ago
- Capecitabine and Angular Cheilitis - 12 seconds ago
- Xyrem and Brain Herniation - 13 seconds ago
- Sulfamethoxazole and Hair Follicle Tumor Benign - 13 seconds ago
- Xiidra and Quinapril drug interaction - 13 seconds ago
- Divalproex Sodium and Bedridden - 18 seconds ago
- Actrapid and Pancreatitis Aggravated - 21 seconds ago
- Testosterone and Bactrim drug interaction - 29 seconds ago
- Dymista and Abnormal Sensation In Eye - 30 seconds ago